echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Synthetic Routes of 1-(6-Chloro-3-pyridazinyl)-3-piperidinemethanol

    The Synthetic Routes of 1-(6-Chloro-3-pyridazinyl)-3-piperidinemethanol

    • Last Update: 2023-05-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    1-(6-Chloro-3-pyridazinyl)-3-piperidinemethanol, commonly referred to as 6-Chloropiperidine, is an important chemical compound that finds extensive application in the field of pharmaceuticals and agrochemicals.
    The synthesis of 6-Chloropiperidine involves several steps, which can be broadly classified into two categories: natural and synthetic routes.
    In this article, we will discuss the synthetic routes of 6-Chloropiperidine, which are widely used in the chemical industry due to their ease of scale-up and better yield compared to natural routes.


    One of the most commonly used synthetic routes for the production of 6-Chloropiperidine involves the reaction of 3-amino-2-chloropropanol with 2-piperidone in the presence of a Lewis acid catalyst such as aluminum chloride or ferric chloride.
    This reaction involves the nucleophilic substitution of the amine group of 3-amino-2-chloropropanol with the piperidone group of 2-piperidone, resulting in the formation of 6-Chloropiperidine.


    Another synthetic route for the production of 6-Chloropiperidine involves the reaction of 3-amino-2-chloropropanol with 2-oxopropanamine in the presence of an acid catalyst, such as sulfuric acid or phosphoric acid.
    This reaction also involves nucleophilic substitution, where the amine group of 3-amino-2-chloropropanol is substituted by the oxopropanamine group, resulting in the formation of 6-Chloropiperidine.


    A third synthetic route involves the reaction of 3-amino-2-bromopropanol with 2-piperidone in the presence of a Lewis acid catalyst, such as aluminum chloride or ferric chloride.
    This reaction also results in the formation of 6-Chloropiperidine through nucleophilic substitution.


    The synthetic routes of 6-Chloropiperidine are well-established and are widely used in the chemical industry due to their ease of scale-up and better yield compared to natural routes.
    Furthermore, the use of Lewis acid catalysts, such as aluminum chloride or ferric chloride, allows for the efficient and selective formation of 6-Chloropiperidine.


    In conclusion, 6-Chloropiperidine is an important chemical compound with wide-ranging applications in the pharmaceutical and agrochemical industries.
    The synthetic routes of 6-Chloropiperidine, which involve the reaction of 3-amino-2-chloropropanol with 2-piperidone or 2-oxopropanamine in the presence of a Lewis acid catalyst, are well-established and widely used in the chemical industry.
    These synthetic routes offer several advantages, including ease of scale-up and better yield compared to natural routes, making them an ideal choice for the production of 6-Chloropiperidine.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.